Hydrocortisone BE studies for UK [Design Issues]

posted by HallaGulla – United Kingdom, 2022-05-16 17:37 (52 d 02:08 ago) – Posting: # 22992
Views: 364

Dear All

It would be great if someone can put some light on dose linearity for Hydrocortisone acetate. The information available in the literature is very confusing with few suggesting it's linear between the dose up to 40mg and then few say nonlinear due to absorption and protein binding and show less than dose-proportional increase in AUC.


In case we have to plan this study for the EU/UK do we need to do a study on higher and lower strength both?

Cheers
HG

Complete thread:

UA Flag
Activity
 Admin contact
22,193 posts in 4,651 threads, 1,574 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Thursday 19:45 CEST (Europe/Vienna)

Any sufficiently advanced technology
is indistinguishable from magic.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5